Real Estate
National Health Investors Executive Compensation (FY25)
NHI · Murfreesboro, TN · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025 ◇ D. Eric Mendelsohn | Latest say-on-pay support = May 27, 2026 | Chief executive pay ratio ◇ To the median employee |
Velarion Member: every covered company in Real Estate, with dashboards, peer screens and board-ready briefs. Three seats, one year.
The paid brief on National Health Investors
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Data as of October 22, 2026Latest filing (8-K): May 29, 2026
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Member, one year
301 figures on this page: 290 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
More on National Health Investors
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — D. Eric Mendelsohn: $2,246,596 → $3,652,795 (62.6% higher)
Say-on-pay support: 95.7% → 95.8% (0.1 points higher)
CEO pay ratio: 10:1 → 18:1 (80.0% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is National Health Investors' chief executive and what were they paid?
D. Eric Mendelsohn was paid $3,652,795 in total compensation as President and CEO for fiscal 2025. Mendelsohn's total moved 62.6% higher from the $2,246,596 reported for fiscal 2024.
What was National Health Investors' say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 95.8% of votes cast for or against in favor at the meeting held May 27, 2026.
Which companies are in National Health Investors' peer group?
The disclosed peer group includes American Healthcare REIT, Inc., Broadstone Net Lease, Inc, CareTrust REIT, Inc., Chiron Real Estate Inc. and Community Healthcare Trust Incorporated, among others.
What is National Health Investors' chief executive pay ratio?
The company reported a chief executive pay ratio of 18:1 for fiscal 2025, against median employee compensation of $206,619.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
D. Eric Mendelsohn President and Chief Executive Officer | ◇ | ◇ | — | ◇ | — | — | ◇ | ◇ |
John Spaid Chief Financial Officer, Treasurer, and Executive Vice President of Finance | ◇ | ◇ | — | ◇ | — | — | ◇ | ◇ |
Kristin Gaines Chief Credit Officer | ◇ | ◇ | — | ◇ | — | — | ◇ | ◇ |
Kevin Pascoe Chief Investment Officer | ◇ | ◇ | — | ◇ | — | — | ◇ | ◇ |
David Travis Chief Accounting Officer | ◇ | ◇ | — | ◇ | — | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
D. Eric Mendelsohn President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
John Spaid Executive Vice President of Finance, Chief Financial Officer and Treasurer | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Kevin Pascoe Executive Vice President of Investments and Chief Investment Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Kristin Gaines Senior Vice President and Chief Transaction Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
David Travis Senior Vice President and Chief Accounting Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
D. Eric Mendelsohn CEO and President | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
John Spaid Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Kevin Pascoe Chief Investment Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Kristin Gaines Chief Transaction Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
David Travis Chief Accounting Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
D. Eric Mendelsohn President and CEO | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
John Spaid Executive Vice President of Finance, Chief Financial Officer and Treasurer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Kevin Pascoe Executive Vice President of Investments and Chief Investment Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
David Travis Senior Vice President and Chief Accounting Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Kristin Gaines Senior Vice President and Chief Transaction Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| D. Eric Mendelsohn | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| D. Eric Mendelsohn | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| David L. Travis | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| David L. Travis | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| John L. Spaid | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| John L. Spaid | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Kevin C. Pascoe | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Kevin C. Pascoe | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Kristin S. Gaines | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Kristin S. Gaines | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Kevin Pascoe | RSU | ◇ | ◇ | — | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Kristin Gaines | Option | ◇ | — | ◇ | — |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| David Travis | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | — | |
| D. Mendelsohn | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — | |
| John Spaid | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
D. Eric Mendelsohn
President and CEO · Terms as described in the company’s compensation discussion
| Severance multiple | ◇ |
| Severance base | ◇ |
| Severance cash amount | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
David Travis
Senior Vice President and Chief Accounting Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
Kevin Pascoe
Executive Vice President of Investments and Chief Investment Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
Kristin Gaines
Senior Vice President and Chief Transaction Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Robert A. McCabe, Jr Board chair | ◇ | — | ◇ | — | — | — | ◇ |
Candice W. Todd | ◇ | — | ◇ | — | — | — | ◇ |
Tracy M.J. Colden | ◇ | — | ◇ | — | — | — | ◇ |
James R. Jobe | ◇ | — | ◇ | — | — | — | ◇ |
Charlotte A. Swafford | ◇ | — | ◇ | — | — | — | ◇ |
Robert G. Adams | ◇ | — | ◇ | — | — | — | ◇ |
Robert W. Chapin, Jr | ◇ | — | ◇ | — | — | — | ◇ |
Robert T. Webb | ◇ | — | ◇ | — | — | — | ◇ |
Lilly H. Donohue and D. Eric Mendelsohn served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance member | ◇ |
| Board meeting fee | ◇ |
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- American Healthcare REIT, Inc. AHR
- Broadstone Net Lease, Inc BNL
- CareTrust REIT, Inc. CTRE
- Chiron Real Estate Inc. XRN
- Community Healthcare Trust Incorporated CHCT
- Easterly Government Properties, Inc. DEA
- EPR EPR
- Healthcare Realty Trust Incorporated HR
- LTC Properties, Inc. LTC
- LXP Industrial Trust LXP
- National Healthcare Properties, Inc. NHPAP
- NETSTREIT Corp NTST
- Sabra Health Care REIT, Inc. SBRA
- Sila Realty Trust, Inc. SILA
- Terreno Realty Corporation TRNO
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | May 27, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | May 21, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | May 22, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | May 5, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | May 6, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | May 4, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | May 6, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | May 3, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | May 4, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | May 8, 2017 | = | ◇ | ◇ | ◇ |
| 2015 | May 5, 2016 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Velarion Pro: every company page, peer tools and exports, one seat
One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- D. Eric Mendelsohn (President and CEO), FY2025 total compensation $3,652,795 (base salary $700,000) [exec_comp, SEC accession 0000877860-26-000098, filed 2026-04-03]What this page does not include
Everything above is a fact National Health Investors disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where National Health Investors sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
301 figures on this page: 290 cited to the filing that reported them, 11 calculated from figures it prints.
290 cited to the filing
11 calculated from the filing
Documents cited
- 0000877860-26-000149
- 0000877860-26-0000982025 Director Compensation · 2025 Outstanding Equity Awards at Fiscal Year-End · 2025 Summary Compensation Table · CEO Pay Ratio · and 4 more sections
- 0000877860-25-000111
- 0000877860-25-000063
- 0000877860-24-000054
- 0000877860-23-000064Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000877860-22-000044Say-on-Pay Proposal
- 0000877860-21-000034Say-on-Pay Proposal
- 0000877860-20-000072
- 0000877860-19-000030
- 0000877860-18-000043
- 0000877860-17-000054Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000877860-16-000132Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “National Health Investors executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/NHI (accessed 2026).
Short form: data: Velarion
The paid brief for National Health Investors
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about National Health Investors and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Real Estate rankings
Peers National Health Investors discloses
The companies named in NHI's own disclosed peer group.
American Healthcare REIT, Inc.Broadstone Net Lease, IncCareTrust REIT, Inc.Chiron Real Estate Inc.Community Healthcare Trust IncorporatedEasterly Government Properties, Inc.EPRHealthcare Realty Trust IncorporatedLTC Properties, Inc.LXP Industrial TrustNETSTREIT CorpSabra Health Care REIT, Inc.Sila Realty Trust, Inc.Terreno Realty Corporation
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}